Levodopa motor complications in Parkinson's disease

被引：348

作者：

Obeso, JA ^{[1
]}

Olanow, CW

Nutt, JG

机构：

[1] Clin Univ & Med Sch, Movement Disorders & Basal Ganglia Grp, Dept Neurol & Neurosurg, Ctr Neurosci, Pamplona 31080, Spain

[2] CUNY Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA

[3] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA

来源：

TRENDS IN NEUROSCIENCES | 2000年 / 23卷 / 10期

关键词：

D O I：

10.1016/S1471-1931(00)00031-8

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Parkinson's disease (PD) is an age-related neurodegenerative disorder with an average onset age of 60 years. In the United States, approximately one million persons suffer from PD, and there are 60 000 newly diagnosed cases every year. The estimated cost of PD to society is $27 billion per year. Based on United States Census Bureau projections, it is estimated that the frequency of PD will increase fourfold by the year 2040, making it an even larger burden on patients, their families and society.

引用

页码：S2 / S7

页数：6

共 50 条

[21] Levodopa/carbidopa intestinal gel for pain related to levodopa-induced motor complications in Parkinson's disease
Rinaldi, Domiziana
De Carolis, Lanfranco
Ceriello, Francesco
Bianchini, Edoardo
Pontieri, Francesco E.
NEUROLOGICAL SCIENCES, 2022, 43 (07) : 4571 - 4572
[22] Motor Complications in Parkinson's Disease
Ondo, William G.
INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2011, 121 : 37 - 44
[23] Motor complications of Parkinson's disease
E. Martignoni
G. Riboldazzi
D. Calandrella
N. Riva
Neurological Sciences, 2003, 24 : s27 - s29
[24] Motor complications in Parkinson's disease
Gandhi, S.
Zerenner, T.
Nodehi, A.
Lawton, M.
Grosset, K.
Marshall, V.
Al-Hajraf, F.
Ben-Shlomo, Y.
Hu, M.
Grosset, D.
MOVEMENT DISORDERS, 2023, 38 : S607 - S607
[25] Motor complications of Parkinson's disease
Martignoni, E
Riboldazzi, G
Calandrella, D
Riva, N
NEUROLOGICAL SCIENCES, 2003, 24 (Suppl 1) : S27 - S29
[26] Levodopa, motor fluctuations and dyskinesia in Parkinson's disease
Mueller, Thomas
Russ, Hermann
EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (13) : 1715 - 1730
[27] Does combined levodopa and bromocriptine therapy in Parkinson's disease prevent late motor complications?
Alarcon, F
Cevallos, N
Lees, AJ
EUROPEAN JOURNAL OF NEUROLOGY, 1998, 5 (03) : 255 - 263
[28] Levodopa-induced motor complications on quality of life in Parkinson's Disease patients in Singapore
Manharlal, P. K.
Lim, E. C.
Tan, E-K.
EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 123 - 123
[29] Motor and psychic complications in the long-term treatment of complicated Parkinson's disease with levodopa
Molina, JA
Jiménez-Jiménez, FJ
Ortí-Pareja, M
REVISTA DE NEUROLOGIA, 1999, 28 (10) : 982 - 990
[30] Modulation of levodopa-induced motor response complications by NMDA antagonists in Parkinson's disease
Blanchet, PJ
Papa, SM
Metman, LV
Mouradian, MM
Chase, TN
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1997, 21 (04): : 447 - 453

← 1 2 3 4 5 →